Ecosyste.ms: Papers

Papers: 10.3390/jcm9113682

https://doi.org/10.3390/jcm9113682

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial

Cited by: 13
Author(s): Michael J. Brownstein, Neal G. Simon, Jeffrey D. Long, Jon Yankey, Howard Maibach, Merit Cudkowicz, Christopher S. Coffey, Robin Conwit, Codrin Lungu, Karen E. Anderson, Steven M. Hersch, Dixie Ecklund, Eve Damiano, Debra E. Itzkowitz, Shi-fang Lu, Marianne Chase, Jeremy M. Shefner, Andrew McGarry, Brenda Thornell, Catherine Gladden, Michele Costigan, Padraig O’Suilleabhain, Frederick J. Marshall, Amy Chesire, Paul Deritis, Jamie L. Adams, Peter Hedera, Kelly Lowen, H. Diana Rosas, Amie Hiller, Joseph F. Quinn, Kellie Keith, Andrew P. Duker, Christina Gruenwald, Angela Molloy, Cara Jacob, Stewart A. Factor, Elaine Sperin, Danny Bega, Zsazsa R Brown, Lauren Seeberger, Victor Sung, Melanie Benge, Sandra K. Kostyk, Allison M. Daley, Susan Perlman, Valerie Suski, Patricia Conlon, M. Barrett, Stephanie Lowenhaupt, Mark Quigg, Joel S. Perlmutter, Brenton A. Wright, Elaine Most, Guy Schwartz, Jessica Lamb, Rosalind Chuang, Carlos Singer, Karen Marder, Joyce Ann Moran, J. Robinson Singleton, Meghan Zorn, Paola Wall, Richard Dubinsky, Carolyn Steele Gray, Carolyn Drazinic
Published: about 4 years ago

Software Mentions 1